Open-to-Accrual Therapeutic Trials


Head and Neck Cancer

Protocol ID

Official Title

PI Name

Lead CRC

Disease Site

Phase

RTOG-1216 ClinicalTrials.gov: NCT01810913

Randomized Phase I/III Trials of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

S. Ghamande

Inquiries

Head and Neck Squamous Cell Cancer

II/III